SYNHLA

Pharmaceutical preparations for cell therapy to treat human diseases and disorders; cell therapy products, namely, pharmaceutical preparations to treat cellular disorders, namely, human diseases and disorders

Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; scientific research and development of technology in the field of cell therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for cell therapy